Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
- 1 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 967, 176357
Abstract
No abstract availableKeywords
This publication has 182 references indexed in Scilit:
- Platelet factor-4 (CXCL4/PF-4): An angiostatic chemokine for cancer therapyCancer Letters, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Expression of CXCL14 and its anticancer role in breast cancerBreast Cancer Research and Treatment, 2012
- Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasisBritish Journal of Cancer, 2012
- Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic CancerThe American Journal of Pathology, 2011
- CCL20/CCR6 expression profile in pancreatic cancerJournal of Translational Medicine, 2010
- Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Platelet Chemokines in Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferationInternational Journal of Cancer, 2007
- Regulated expression of platelet factor 4 in human monocytes—role of PARs as a quantitatively important monocyte activation pathwayJournal of Leukocyte Biology, 2005